RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity

X Li, K Jin, TC Cheng, YC Liao, WJ Lee, AS Bhullar… - Biomaterials, 2024 - Elsevier
The field of RNA therapeutics has been emerging as the third milestone in pharmaceutical
drug development. RNA nanoparticles have displayed motile and deformable properties to …

Cracking the Code: Enhancing Molecular Tools for Progress in Nanobiotechnology

YI Avila, LP Rebolledo, E Skelly… - ACS Applied Bio …, 2024 - ACS Publications
Nature continually refines its processes for optimal efficiency, especially within biological
systems. This article explores the collaborative efforts of researchers worldwide, aiming to …

[HTML][HTML] RNA nanotechnology on the horizon: Self-assembly, chemical modifications, and functional applications

JM Stewart - Current Opinion in Chemical Biology, 2024 - Elsevier
RNA nanotechnology harnesses the unique chemical and structural properties of RNA to
build nanoassemblies and supramolecular structures with dynamic and functional …

RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect

X Li, K Jin, YC Liao, WJ Lee, LC Chen… - Molecular …, 2024 - ACS Publications
Nucleoside analogs are potent inhibitors for cancer treatment, but the main obstacles to their
application in humans are their toxicity, nonspecificity, and lack of targeted delivery tools …

[PDF][PDF] Conversion of Chemical Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload Stoichiometry for Optimal Biodistribution in Cancer …

C Xu, H Yin, T Yudhistira, Z Li, DW Binzel, P Guo - 2024 - isrnn.ia-bs.org
Active targeting-mediated nanodelivery takes advantages of ligand-receptor specificity to
avoid non-specific distribution, holding great promise for the treatment of a spectrum of …